A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001

NCT05121831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: DGX-001Dose 1
DRUG: DGX-001 Dose 2
DRUG: DGX-001 Dose 3
DRUG: DGX-001 Dose 4
DRUG: MAD dose panel of DGX-001

Sponsor

Digestome Therapeutics